CymitQuimica logo
Cycle cellulaire/point de contrôle

Cycle cellulaire/point de contrôle

Les inhibiteurs du cycle cellulaire/des points de contrôle sont des composés qui perturbent la progression normale du cycle cellulaire, en particulier aux points de contrôle régulateurs clés. Ces inhibiteurs sont cruciaux pour étudier la division cellulaire, comprendre la prolifération des cellules cancéreuses et développer des thérapies anticancéreuses. En ciblant des phases spécifiques du cycle cellulaire, ces inhibiteurs peuvent induire un arrêt du cycle cellulaire, conduisant à l'apoptose ou à la sénescence des cellules à division rapide. Chez CymitQuimica, nous offrons une large gamme d'inhibiteurs de haute qualité du cycle cellulaire/des points de contrôle pour soutenir vos recherches en biologie du cancer, biologie cellulaire et développement de médicaments.

Sous-catégories appartenant à la catégorie "Cycle cellulaire/point de contrôle"

Affichez 10 plus de sous-catégories

3480 produits trouvés pour "Cycle cellulaire/point de contrôle"

Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • Dyrk1A-IN-4
    Targetmol
    + Info

    Dyrk1A-IN-4

    CAS :
    <p>Dyrk1A-IN-4, compound 48, is an oral DYRK1A/DYRK2 inhibitor with IC50s: 2 nM (DYRK1A), 6 nM (DYRK2), anticancer properties.</p>
    Formule :C14H13F3N6
    Couleur et forme :Solid
    Masse moléculaire :322.29

    Ref: TM-T60867

  • Uridine 3',5'-diphosphate
    Targetmol
    + Info

    Uridine 3',5'-diphosphate

    CAS :
    <p>Uridine 3′,5′-diphosphate (3′,5′-UDP; Compound pUp) serves as a competitive RNase inhibitor [1].</p>
    Formule :C9H14N2O12P2
    Couleur et forme :Solid
    Masse moléculaire :404.16

    Ref: TM-T87599

  • β-catenin-IN-8
    Targetmol
    + Info

    β-catenin-IN-8

    CAS :
    <p>β-catenin-IN-8 (Compound 25) is an inhibitor of β-catenin. It effectively lowers the levels of both β-catenin and c-Myc proteins and suppresses Wnt target genes (Fgf20 and Sall4). Additionally, β-catenin-IN-8 exhibits anticancer activity against colorectal cancer and possesses metabolic stability.</p>
    Formule :C15H12ClN3O2S
    Couleur et forme :Solid
    Masse moléculaire :333.79

    Ref: TM-T201581

  • ROCK-IN-11
    Targetmol
    + Info

    ROCK-IN-11

    CAS :
    <p>ROCK-IN-11 (example 94) is an effective inhibitor of ROCK1 and ROCK2, with an IC50 of ≤ 5 μM, and plays a significant role in cancer research.</p>
    Formule :C22H20N4O4S
    Couleur et forme :Solid
    Masse moléculaire :436.484

    Ref: TM-T204468

  • Le logo de CymitQuimica
    Targetmol
    + Info

    Dyrk1A-IN-2

    <p>Dyrk1A-IN-2 is a DYRK1A inhibitor (EC50: 37 nM). dyrk1A-IN-2 exhibits efficient promotion of human β-cell replication, as well as low cytotoxicity.</p>
    Formule :C27H32N6O4
    Couleur et forme :Solid
    Masse moléculaire :504.58

    Ref: TM-T63440

  • CDK2-IN-18
    Targetmol
    + Info

    CDK2-IN-18

    CAS :
    <p>CDK2-IN-18 (compound 8q) serves as a powerful inhibitor of CDK 2/E and CDK 4/D1, showing IC50 values of 8 nM and 46 nM, respectively. It effectively inhibits tumor cell proliferation [1].</p>
    Formule :C21H23N7O2S
    Couleur et forme :Solid
    Masse moléculaire :437.52

    Ref: TM-T86027

  • 2'-O-MOE-GTP
    Targetmol
    + Info

    2'-O-MOE-GTP

    CAS :
    <p>2'-O-MOE-GTP is a nucleotide analog utilized in the synthesis of oligonucleotides.</p>
    Formule :C13H22N5O15P3
    Couleur et forme :Solid
    Masse moléculaire :581.26

    Ref: TM-TSW-00970

  • PKMYT1-IN-7
    Targetmol
    + Info

    PKMYT1-IN-7

    CAS :
    <p>PKMYT1-IN-7 (compound 7) is an orally active PKMYT1 inhibitor with IC50 values of 1.6 nM for PKMYT1 and 0.06 μM for pCDK1. It inhibits the phosphorylation of CDK1 at T14 and Y15 sites and exhibits anticancer activity both in vitro and in vivo.</p>
    Formule :C17H18FN5O3
    Couleur et forme :Solid
    Masse moléculaire :359.355

    Ref: TM-T206777

  • PT109
    Targetmol
    + Info

    PT109

    CAS :
    PT109 is a multikinase inhibitor that targets JNK and other kinases, playing a crucial role in anti-inflammatory, antioxidative, neurogenic, and synaptogenic processes. Specifically, PT109 inhibits JNK isoforms with the following IC50 values: JNK1 at 0.143 μM, JNK2 at 0.831 μM, and JNK3 at 0.285 μM. It also inhibits SGK isoforms (SGK1: IC50=1.34 μM; SGK2: IC50=5.6 μM; SGK3: IC50=26.4 μM) and ROCK2 (IC50=34 μM). Additionally, PT109 reprograms polymorphic glioblastoma multiforme (GBM) into oligodendroglia via the PTBP1/PKM1/2 pathway and alters the metabolic pattern of GBM to exhibit antiglioma activity.
    Formule :C23H31N3OS2
    Couleur et forme :Solid
    Masse moléculaire :429.64

    Ref: TM-T201273

  • Le logo de CymitQuimica
    Targetmol
    + Info

    FT3967385

    <p>FT3967385: New USP30 inhibitor boosts mitochondrial ubiquitylation via PINK1-PARKIN.</p>
    Formule :C21H19N5O2
    Couleur et forme :Solid
    Masse moléculaire :373.41

    Ref: TM-T61512

  • LY 254155
    Targetmol
    + Info

    LY 254155

    CAS :
    <p>LY 254155, an antifolate,binds to mFBP and inhibits hGARFT with Kis of 1.7±0.1 and 2.1±0.2 nM, respectively.</p>
    Formule :C19H23N5O6S
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :449.48

    Ref: TM-T11922

  • T-2513 hydrochloride
    Targetmol
    + Info

    T-2513 hydrochloride

    CAS :
    <p>T-2513 hydrochloride: selective topoisomerase I inhibitor, binds DNA complex, halts DNA/RNA synthesis, causes cell death.</p>
    Formule :C25H28ClN3O5
    Couleur et forme :Solid
    Masse moléculaire :485.96

    Ref: TM-T63225

  • CDK7-IN-31
    Targetmol
    + Info

    CDK7-IN-31

    CAS :
    <p>CDK7-IN-31 (compound 13) is an effective and orally active inhibitor of cyclin-dependent kinase 7 (CDK7) with a dissociation constant (Kd) of 0.18 nM. This compound exhibits anticancer activity.</p>
    Formule :C27H32F5N6O2P
    Couleur et forme :Solid
    Masse moléculaire :598.55

    Ref: TM-T201665

  • CDK6-IN-1
    Targetmol
    + Info

    CDK6-IN-1

    CAS :
    <p>CDK6-IN-1 (compound 4i) is an inhibitor of CDK6 that suppresses cell growth and induces cell cycle arrest at the G1 phase.</p>
    Formule :C30H23N5
    Couleur et forme :Solid
    Masse moléculaire :453.54

    Ref: TM-T201591

  • PKMYT1-IN-2
    Targetmol
    + Info

    PKMYT1-IN-2

    CAS :
    <p>PKMYT1-IN-2 (compound 2) serves as a powerful inhibitor of PKMYT1, exhibiting an IC 50 of 5.7 nM. Additionally, it effectively suppresses the proliferation of HCC1569 cells with an IC 50 of 22 nM [1].</p>
    Formule :C22H19N5O2
    Couleur et forme :Solid
    Masse moléculaire :385.42

    Ref: TM-T87219

  • 2′-F-UDP
    Targetmol
    + Info

    2′-F-UDP

    CAS :
    <p>2′-F-UDP is a nucleotide analogue used in the synthesis of oligonucleotides.</p>
    Formule :C9H13FN2O11P2
    Couleur et forme :Solid
    Masse moléculaire :406.15

    Ref: TM-TSW-00958

  • WEE1-IN-11
    Targetmol
    + Info

    WEE1-IN-11

    CAS :
    WEE1-IN-11 (Compound 13) serves as a potent CDK2 inhibitor with an IC50 of 2.0 nM. It exhibits inhibitory effects on several cell lines, including NCI-H446, A427, OVCAR3, C33A, and WiDr, with respective IC50 values of 93.9, 34.5, 86.7, 23.1, and 85 nM.
    Formule :C26H29FN8OS2
    Couleur et forme :Solid
    Masse moléculaire :552.69

    Ref: TM-T200924

  • DB18
    Targetmol
    + Info

    DB18

    CAS :
    <p>DB18 serves as a potent, selective inhibitor of CDC2-like kinases (CLKs), exhibiting IC50 values between 10-30 nM for CLK1, CLK2, and CLK4. Additionally, it possesses anti-tumor activity [1].</p>
    Formule :C24H18ClN7O3
    Couleur et forme :Solid
    Masse moléculaire :487.9

    Ref: TM-T86165

  • WRN inhibitor 7
    Targetmol
    + Info

    WRN inhibitor 7

    CAS :
    <p>WRN inhibitor 7 (Compound h6), a potent inhibitor of Werner syndrome helicase, demonstrates effective suppression of WRN's helicase and ATPase activities with IC50 values of 9.8 μM and 15.8 μM, respectively. This compound is utilized in the study of microsatellite instable (MSI) cancers [1].</p>
    Formule :C27H23N3O6
    Couleur et forme :Solid
    Masse moléculaire :485.49

    Ref: TM-T87635

  • VPC-80051
    Targetmol
    + Info

    VPC-80051

    CAS :
    <p>VPC-80051 is an hnRNP A1 splicing activity inhibitor that directly interacts with the hnRNP A1 RBD and reduces AR-V7 messenger levels in the 22Rv1 CRPC cell line. VPC-80051 is applicable in prostate cancer research.</p>
    Formule :C16H13F2N3O
    Couleur et forme :Solid
    Masse moléculaire :301.291

    Ref: TM-T204737